company background image
IMP

Imexpharm HOSE:IMP Stock Report

Last Price

₫62.10k

Market Cap

₫4.1t

7D

1.6%

1Y

-10.3%

Updated

15 Aug, 2022

Data

Company Financials +
IMP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance2/6
Financial Health5/6
Dividends2/6

IMP Stock Overview

Imexpharm Corporation manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally.

Rewards

Trading at 9.7% below our estimate of its fair value

Earnings are forecast to grow 40.44% per year

Risk Analysis

No risks detected for IMP from our risk checks.

Imexpharm Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Imexpharm
Historical stock prices
Current Share Price₫62,100.00
52 Week High₫86,400.00
52 Week Low₫57,000.00
Beta0.43
1 Month Change-4.17%
3 Month Change-5.91%
1 Year Change-10.26%
3 Year Change68.54%
5 Year Change35.93%
Change since IPO27.65%

Recent News & Updates

Shareholder Returns

IMPVN PharmaceuticalsVN Market
7D1.6%-0.03%0.9%
1Y-10.3%-3.6%-8.1%

Return vs Industry: IMP underperformed the VN Pharmaceuticals industry which returned -3.6% over the past year.

Return vs Market: IMP underperformed the VN Market which returned -8.1% over the past year.

Price Volatility

Is IMP's price volatile compared to industry and market?
IMP volatility
IMP Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement7.1%
10% most volatile stocks in VN Market9.6%
10% least volatile stocks in VN Market3.8%

Stable Share Price: IMP is not significantly more volatile than the rest of VN stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: IMP's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19771,225Dao Tranhttps://www.imexpharm.com

Imexpharm Corporation manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally. The company’s products include oral and injectable antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-histamines, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals. It is also involved in the import and export of medical equipment and supplies, chemicals, materials for medicine manufacturing and packaging, and chemicals used for sterilization or disinfection in humans.

Imexpharm Corporation Fundamentals Summary

How do Imexpharm's earnings and revenue compare to its market cap?
IMP fundamental statistics
Market Cap₫4.14t
Earnings (TTM)₫176.27b
Revenue (TTM)₫1.32t

23.5x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IMP income statement (TTM)
Revenue₫1.32t
Cost of Revenue₫696.03b
Gross Profit₫625.40b
Other Expenses₫449.14b
Earnings₫176.27b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.64k
Gross Margin47.33%
Net Profit Margin13.34%
Debt/Equity Ratio5.3%

How did IMP perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

57%

Payout Ratio